12.02.10
Advinus Therapeutics and Corning Inc. entered a collaboration to bring Corning Epic label-free detection technology to India. Advinus will leverage the Corning Epic technology to enhance its own drug discovery capabilities and to provide assay development and screening services to companies both in India and abroad.
Corning Epic technology combines biochemical detection and cellular analysis on a single label-free platform to enhance understanding of biological activity for a range of research applications. Corning’s technology is used to identify targets, pathways and interactions in order to help provide more biologically relevant data.
“This collaboration is in line with Corning’s strategy of bringing innovative technology to India through collaborations with leading Indian companies,” said Rustom Desai, president, Corning India.
Dr. Kasim Mookhtiar, chief scientific officer of Advinus, said, “This collaboration emphasizes Advinus’ commitment to set up unique pharma R&D services in India and to explore new and cutting-edge technologies to enhance our drug discovery capabilities.”
Corning Epic technology combines biochemical detection and cellular analysis on a single label-free platform to enhance understanding of biological activity for a range of research applications. Corning’s technology is used to identify targets, pathways and interactions in order to help provide more biologically relevant data.
“This collaboration is in line with Corning’s strategy of bringing innovative technology to India through collaborations with leading Indian companies,” said Rustom Desai, president, Corning India.
Dr. Kasim Mookhtiar, chief scientific officer of Advinus, said, “This collaboration emphasizes Advinus’ commitment to set up unique pharma R&D services in India and to explore new and cutting-edge technologies to enhance our drug discovery capabilities.”